Viewing Study NCT01552005


Ignite Creation Date: 2025-12-25 @ 3:23 AM
Ignite Modification Date: 2025-12-26 @ 2:03 AM
Study NCT ID: NCT01552005
Status: COMPLETED
Last Update Posted: 2016-06-07
First Post: 2012-02-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Description of Drug Utilization and Assessment of Impact of Saxagliptin on Health Status of Patients With Type 2 Diabetes in France
Sponsor: AstraZeneca
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module